Journals / Turkish Journal of Medical Sciences / 2019 / Cilt: 49 - Sayı: 6

Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI

Pages
1626–1633
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

High-resolution craniumimaging with the 3D-SPACE technique using 3T-MRI seems to be helpful for detection of the optic pathway morphology and pathologiesin NF-1 patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: We aimed to evaluate the size/tortuosity of the optic nerve (ON) and the dilatation of the ON sheath (ONS) inneurofibromatosis type 1 (NF-1) patients with 3T-MRI, and to assess the usefulness of 3D-SPACE in imaging the optic pathway, ON,and ONS in NF-1 patients.Materials and methods: Twenty consecutive NF-1 patients without optic pathway glioma (OPG) (Group 1), 16 consecutive NF-1patients with OPG (Group 2), and 19 controls were included in this study.
📊
Key Findings & Data:The thickness and tortuosity of the ON and the diameter ofthe ONS were measured on STIR and 3D-SPACE images.Results: The thickness of the ON was similar in all groups on STIR images (P>0.05).
💡
Conclusion & Impact:High-resolution craniumimaging with the 3D-SPACE technique using 3T-MRI seems to be helpful for detection of the optic pathway morphology and pathologiesin NF-1 patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: We aimed to evaluate the size/tortuosity of the optic nerve (ON) and the dilatation of the ON sheath (ONS) inneurofibromatosis type 1 (NF-1) patients with 3T-MRI, and to assess the usefulness of 3D-SPACE in imaging the optic pathway, ON,and ONS in NF-1 patients.Materials and methods: Twenty consecutive NF-1 patients without optic pathway glioma (OPG) (Group 1), 16 consecutive NF-1patients with OPG (Group 2), and 19 controls were included in this study. The thickness and tortuosity of the ON and the diameter ofthe ONS were measured on STIR and 3D-SPACE images.Results: The thickness of the ON was similar in all groups on STIR images (P>0.05). The mean ONS diameter was higher in Group 2with this sequence (P=0.009). Controls had significantly lower grades of ON tortuosity than Groups 1 and 2 (P=0.001), and Group 1 hadsignificantly lower ON tortuosity compared to Group 2 (P=0.001). Severe tortuosity was only detected in Group 2.Conclusion: ON tortuosity and ONS diameter were increased in NF-1 patients in the presence of OPG. High-resolution craniumimaging with the 3D-SPACE technique using 3T-MRI seems to be helpful for detection of the optic pathway morphology and pathologiesin NF-1 patients.

🔖

Cite This Article

VARAN, A., ANLAR, B., KANSU, T., BEYAZAL, M., SARAÇ, Ö., ALGIN, O. (2022). Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 6, 1626–1633. https://ajindex.com/articles/609979

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. Journal of Medical Genetics 2007; 44: 81-88
  2. Friedman JM. Neurofibromatosis 1. In: Pagon RA, Bird TC, Dolan CR, Stephens K (editors). Gene Reviews [Internet]. Seattle, WA, USA: University of Washington, Seattle; 1998
  3. Rosenfeld A, Listernick R, Charrow J, Goldman S. Neurofibromatosis type 1 and high-grade tumors of the central nervous system. Child’s Nervous System 2010; 26: 663-667
  4. Pascual-Castroviejo I, Pascual-Pascual SI, Velázquez-Fragua R, Viaño J, García-Segura JM et al. Neurofibromatosis type 1 and optic pathway gliomas. A series of 80 patients. Revista de Neurologia 2008; 46: 530-536
  5. Hernáiz Driever P, von Hornstein S, Pietsch T, Kortmann R, Warmuth-Metz M et al. Natural history and management of low-grade glioma in NF-1 children. Journal of NeuroOncology 2010; 100: 199-207
  6. Zuccoli G, Ferrozzi F, Signorini M, Virdis G, Troiso G. Optic pathway gliomas in patients with neurofibromatosis type 1: clinical-neuroradiological integrated approach. La Radiologia Medica 2001; 101: 382-385
  7. Liu GT, Brodsky MC, Phillips PC, Belasco J, Janss A et al. Optic radiation involvement in optic pathway gliomas in neurofibromatosis. American Journal of Ophthalmology 2004; 137: 407-414
  8. Levin MH, Brodsky MC, Phillips PC, Belasco J, Janss A et al. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening. British Journal of Ophthalmology 2016; 100: 510-514
  9. Dincer A, Yener U, Ozek MM. Hydrocephalus in patients with neurofibromatosis type 1: MR imaging findings and the outcome of endoscopic third ventriculostomy. American Journal of Neuroradiology 2011; 32: 643-646
  10. Maloney E, Stanescu AL, Perez FA, Iyer RS, Otto RK et al. Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary? Pediatric Radiology 2018; 48: 1472-1484
  11. Algin O. Evaluation of hydrocephalus patients with 3D-SPACE technique using variant FA mode at 3T. Acta Neurologica Belgica 2018; 118: 169-178
  12. Armstrong GT, Localio AR, Feygin T, Bilaniuk L, Phillips PC et al. Defining optic nerve tortuosity. American Journal of Neuroradiology 2007; 28: 666-671
  13. Lövblad KO, Remonda L, Ozdoba C, Huber P, Schroth G. Dural ectasia of the optic nerve sheath in neurofibromatosis type 1: CT and MR features. Journal of Computer Assisted